Maegan L. Sheehan

1.5k total citations · 1 hit paper
9 papers, 727 citations indexed

About

Maegan L. Sheehan is a scholar working on Infectious Diseases, Animal Science and Zoology and Epidemiology. According to data from OpenAlex, Maegan L. Sheehan has authored 9 papers receiving a total of 727 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Infectious Diseases, 3 papers in Animal Science and Zoology and 3 papers in Epidemiology. Recurrent topics in Maegan L. Sheehan's work include SARS-CoV-2 and COVID-19 Research (7 papers), Viral gastroenteritis research and epidemiology (4 papers) and COVID-19 Clinical Research Studies (3 papers). Maegan L. Sheehan is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), Viral gastroenteritis research and epidemiology (4 papers) and COVID-19 Clinical Research Studies (3 papers). Maegan L. Sheehan collaborates with scholars based in United States, South Africa and Australia. Maegan L. Sheehan's co-authors include Alejandro B. Balazs, Kerri St. Denis, David J. Gregory, Cristhian Berrios, Wilfredo F. García-Beltrán, A. John Iafrate, Christina C. Chang, Adam D. Nitido, Blake M. Hauser and Aaron G. Schmidt and has published in prestigious journals such as Cell, Viruses and EBioMedicine.

In The Last Decade

Maegan L. Sheehan

8 papers receiving 718 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant

2022 651 citations Wilfredo F. García-Beltrán, Kerri St. Denis et al. Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Maegan L. Sheehan United States	6	663	154	100	100	81	9	727
Onosereme Ofoman United States	3	768 1.2×	192 1.2×	105 1.1×	128 1.3×	86 1.1×	3	821
Cristhian Berrios United States	3	769 1.2×	192 1.2×	105 1.1×	130 1.3×	86 1.1×	4	823
Angelique Hœlzemer Germany	6	620 0.9×	151 1.0×	92 0.9×	144 1.4×	79 1.0×	7	734
Dennis Schaefer-Babajew United States	4	564 0.9×	108 0.7×	108 1.1×	70 0.7×	67 0.8×	5	639
Ann-Kathrin Wallisch Germany	4	671 1.0×	175 1.1×	108 1.1×	103 1.0×	91 1.1×	4	713
Justin DaSilva United States	5	509 0.8×	121 0.8×	101 1.0×	58 0.6×	71 0.9×	6	598
Alina Seidel Germany	8	679 1.0×	146 0.9×	68 0.7×	78 0.8×	109 1.3×	12	736
Charles Kevin Tiu Singapore	3	765 1.2×	108 0.7×	56 0.6×	76 0.8×	131 1.6×	4	811
Bethany Girard United States	9	590 0.9×	130 0.8×	120 1.2×	111 1.1×	120 1.5×	24	694
Vivian Chih-Wei Chen Singapore	2	696 1.0×	98 0.6×	54 0.5×	70 0.7×	121 1.5×	3	729

Countries citing papers authored by Maegan L. Sheehan

Since Specialization

Citations

This map shows the geographic impact of Maegan L. Sheehan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maegan L. Sheehan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maegan L. Sheehan more than expected).

Fields of papers citing papers by Maegan L. Sheehan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maegan L. Sheehan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maegan L. Sheehan. The network helps show where Maegan L. Sheehan may publish in the future.

Co-authorship network of co-authors of Maegan L. Sheehan

This figure shows the co-authorship network connecting the top 25 collaborators of Maegan L. Sheehan. A scholar is included among the top collaborators of Maegan L. Sheehan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maegan L. Sheehan. Maegan L. Sheehan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

1.

Roederer, Alex, Kerri St. Denis, Maegan L. Sheehan, et al.. (2024). Ongoing evolution of SARS-CoV-2 drives escape from mRNA vaccine-induced humoral immunity. Cell Reports Medicine. 5(12). 101850–101850. 1 indexed citations

2.

Gálvez, Nicolás M. S., et al.. (2024). QuickFit: A High-Throughput RT-qPCR-Based Assay to Quantify Viral Growth and Fitness In Vitro. Viruses. 16(8). 1320–1320.

3.

Freeman, Michael L., Oladayo A. Oyebanji, Daniela Moïsi, et al.. (2023). Association of Cytomegalovirus Serostatus With Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine Responsiveness in Nursing Home Residents and Healthcare Workers. Open Forum Infectious Diseases. 10(2). ofad063–ofad063. 12 indexed citations

4.

Hauser, Blake M., Jared Feldman, Maya Sangesland, et al.. (2022). Cross-reactive SARS-CoV-2 epitope targeted across donors informs immunogen design. Cell Reports Medicine. 3(12). 100834–100834. 4 indexed citations

5.

García-Beltrán, Wilfredo F., Kerri St. Denis, Angelique Hœlzemer, et al.. (2022). mRNA-based COVID-19 vaccine boosters induce neutralizing immunity against SARS-CoV-2 Omicron variant. Cell. 185(3). 457–466.e4. 651 indexed citations breakdown →

6.

Bartsch, Yannic C., Jaewon Kang, Madeleine D. Burns, et al.. (2022). BNT162b2 induces robust cross-variant SARS-CoV-2 immunity in children. npj Vaccines. 7(1). 158–158. 9 indexed citations

7.

Canaday, David H., Oladayo A. Oyebanji, Elizabeth M. White, et al.. (2022). COVID-19 vaccine booster dose needed to achieve Omicron-specific neutralisation in nursing home residents. EBioMedicine. 80. 104066–104066. 28 indexed citations

8.

Burns, Madeleine D., Brittany P. Boribong, Yannic C. Bartsch, et al.. (2022). Durability and Cross-Reactivity of SARS-CoV-2 mRNA Vaccine in Adolescent Children. Vaccines. 10(4). 492–492. 9 indexed citations

9.

García-Beltrán, Wilfredo F., Kerri St. Denis, Angelique Hœlzemer, et al.. (2021). mRNA-Based COVID-19 Vaccine Boosters Induce Neutralizing Immunity Against SARS-CoV-2 Omicron Variant. SSRN Electronic Journal. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact